Molecular Docking and Structure-Based Drug Design Strategies
By L. Ferreira, Ricardo N Dos Santos, Glaucius Oliva, Adriano Defini Andricopulo. 2015
2,080 citations recorded by the source corpus.
Pharmaceutical research has successfully incorporated a wealth of molecular modeling methods, within a variety of drug discovery programs, to study complex biological and chemical systems. The integration of computational and experimental strategies has been of great value in the identification and development of novel promising compounds. Broadly used in modern drug design, molecular docking methods explore the ligand conformations adopted within the binding sites of macromolecular targets. This approach also estimates the ligand-receptor binding free energy by evaluating critical phenomena involved in the intermolecular recognition process. Today, as a variety of docking algorithms are available, an understanding of the advantages and limitations of each method is of fundamental importance in the development of effective strategies and the generation of relevant results. The purpose of this review is to examine current molecular docking strategies used in drug discovery and medicinal chemistry, exploring the advances in the field and the role played by the integration of structure- and ligand-based methods.
Subfields: Computational Theory and Mathematics, Organic Chemistry, Computational Chemistry & Drug Discovery
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- João P. G. L. M. Rodrigues
- Alexandre M. J. J. Bonvin
- Masha Karelina
- Ron O. Dror
- Joseph J. Noh
- Li C. Xue
- Anna Vangone
- Adrien S. J. Melquiond
In Organic Chemistry
- Joseph J. Noh
- Masha Karelina
- Ron O. Dror
- Maria Batool
- Jure Leskovec
- Yuxiao Dong
- Giulio Rastelli
- Sangdun Choi
In Computational Chemistry & Drug Discovery
- João P. G. L. M. Rodrigues
- Alexandre M. J. J. Bonvin
- Maria Batool
- Jure Leskovec
- Yuxiao Dong
- Joseph J. Noh
- Masha Karelina
- Ron O. Dror
Citations in the corpus
- A Structure-Based Drug Discovery Paradigm (2019, methodology): “These methods have provided three-dimensional (3D) structures of more than 100,000 proteins [7].”
- Performance of HADDOCK and a simple contact-based protein–ligand binding affinity predictor in the D3R Grand Challenge 2 (2017, methodology): “Integrated with data from the experimental techniques like X-ray crystallography and Nuclear Magnetic Resonance, docking has become a powerful tool in designing novel therapeutics [2].”
- How accurately can one predict drug binding modes using AlphaFold models? (2023, methodology): “…gone into development of computational docking methods for predicting ligand-binding modes, which have dramatically accelerated this process in cases where a high-resolution experimentally determined structure of the target protein is available ( Ferreira et al., 2015 ; Pinzi and Rastelli, 2019 ).”
- A Review on Applications of Computational Methods in Drug Screening and Design (2020, background): “Molecular docking, which predicts interaction patterns between proteins and small molecules as wel as proteins and proteins, to evaluate the binding between two molecules [52], is widely used in the field of drug screening and design.”
- Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management (2023, methodology): “The generated model can then be refined using experimental data to obtain an accurate structure of the protein 49 .”
- OGB-LSC: A Large-Scale Challenge for Machine Learning on Graphs (2021, methodology): “Using fast and accurate ML models to approximate DFT enables diverse downstream applications, such as property prediction for organic photovaltaic devices (Cao and Xue, 2014) and structure-based virtual screening for drug discovery (Ferreira et al., 2015).”
- Molecular Docking: Shifting Paradigms in Drug Discovery (2019, methodology): “The possibilities offered by molecular docking in drug discovery are well established [3,5,7,18,47,49,50,63].”